Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease

被引:0
|
作者
Anna-Maria Schneider
Daniel Weghuber
Benjamin Hetzer
Andreas Entenmann
Thomas Müller
Georg Zimmermann
Sebastian Schütz
Wolf-Dietrich Huber
Judith Pichler
机构
[1] Paracelsus Medical University,Department of Pediatrics
[2] Innsbruck Medical University,Departments of Pediatrics
[3] Paris Lodron University,Department of Mathematics
[4] Paracelsus Medical University,Spinal Cord Injury and Tissue Regeneration Centre Salzburg
[5] Medical University Vienna,Department of Pediatric Nephrology and Gastroenterology
来源
关键词
Crohn’s disease; Ulcerative colitis; Paediatrics; Integrin antagonist;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Safety and Efficacy of Vedolizumab Use in Older Patients With Inflammatory Bowel Disease
    Shivashankar, Raina
    Aberra, Faten
    Ladd, Antonio Mendoza
    Lichtenstein, Gary R.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S404 - S405
  • [42] Use of Vedolizumab in Inflammatory Bowel Disease: A Single-Center Experience
    Erdogan, Cagdas
    Yesil, Bayram
    Bacaksiz, Ferhat
    Ari, Derya
    Gokbulut, Volkan
    Yuksel, Mahmut
    Ozin, Yasemin Ozderin
    Kayacetin, Ertugrul
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2022, 33 (10): : 831 - 837
  • [43] Optic Neuritis Associated or Not with TNF Antagonists in Patients with Inflammatory Bowel Disease
    Alexandre, Benjamin
    Vandermeeren, Yves
    Dewit, Olivier
    Moreels, Tom
    de Boer, Nanne
    Dhar, Anjan
    Ziady, Chris
    Shitrit, Ariella Bar-Gil
    Steinwurz, Flavio
    Jojic, Njegica
    Costantino, Giuseppe
    Bihin, Benoit
    Rahier, Jean-Francois
    Katsanos, Konstantinos H.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 (05): : 541 - 548
  • [44] Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease
    Dubinsky, Marla C.
    Cross, Raymond K.
    Sandborn, William J.
    Long, Millie
    Song, Xue
    Shi, Nianwen
    Ding, Yao
    Eichner, Samantha
    Pappalardo, Brandee
    Ganguli, Arijit
    Wang, Anthony
    [J]. INFLAMMATORY BOWEL DISEASES, 2018, 24 (09) : 1876 - 1882
  • [45] Evaluation of the Use of Vedolizumab in 46 Patients With Inflammatory Bowel Disease in Brazil
    Steinwurz, Flavio
    Carvalho, Nayara Salgado
    Flaquer, Fernando Seefelder
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S428 - S428
  • [46] INFLIXIMAB USE IN ADOLESCENTS WITH INFLAMMATORY BOWEL DISEASE
    Goodhand, J.
    Tang, J.
    Naik, S.
    Croft, N. M.
    Lindsay, J. O.
    [J]. GUT, 2009, 58 : A63 - A64
  • [47] Combination treatment with vedolizumab and anti-TNF-α in inflammatory bowel disease: safety data
    Buer, L.
    Hoivik, M. L.
    Medhus, A. W.
    Moum, B.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S341 - S342
  • [48] Infliximab Use in Adolescents with Inflammatory Bowel Disease
    Goodhand, James
    Tang, Joanna W.
    Naik, Sandhia
    Croft, Nicholas
    Lindsey, James O.
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A657 - A657
  • [49] Complementary and alternative medicine: Use in children and adolescents with inflammatory bowel disease in Switzerland
    Guilcher, K.
    Pittet, V
    Petit, L. M.
    Heyland, K.
    Braegger, C.
    Nydegger, A.
    Garzoni, L.
    Schibli, S.
    Spalinger, J.
    Righini-Grunder, F.
    Sokollik, C.
    [J]. SWISS MEDICAL WEEKLY, 2022, 152 : 2S - 2S
  • [50] The Use of 5-Aminosalicylic Acid in Children and Adolescents With Inflammatory Bowel Disease
    Sokollik, Christiane
    Fournier, Nicolas
    Rizzuti, David
    Braegger, Christian P.
    Nydegger, Andreas
    Schibli, Susanne
    Spalinger, Johannes
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2018, 52 (10) : E87 - E91